UnitedHealth reported $8.9 billion in operating cash flow for Q1, supporting share buybacks, debt reduction, dividends, and acquisitions. The company plans at least $2 billion in share repurchases by June 2026 while aiming to strengthen its balance sheet. Investments of $1.5 billion in AI cut manual contact costs by 76% and improved claims processing efficiency. Adjusted EPS of $7.23 surpassed consensus by nearly 10%, with operating margins expanding year-over-year. Despite declines in Medicare Advantage and ACA membership, management focuses on profitability and margin recovery over growth.
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
